SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020703
Filing Date
2023-05-11
Accepted
2023-05-10 18:13:11
Documents
90
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fdmt-20230331.htm   iXBRL 10-Q 3067850
2 EX-31.1 fdmt-ex31_1.htm EX-31 25384
3 EX-31.2 fdmt-ex31_2.htm EX-31 25280
4 EX-32.1 fdmt-ex32_1.htm EX-32 16033
  Complete submission text file 0000950170-23-020703.txt   11211815

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fdmt-20230331_cal.xml EX-101.CAL 45152
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fdmt-20230331.xsd EX-101.SCH 79976
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fdmt-20230331_lab.xml EX-101.LAB 559002
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fdmt-20230331_pre.xml EX-101.PRE 448347
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fdmt-20230331_def.xml EX-101.DEF 303816
84 EXTRACTED XBRL INSTANCE DOCUMENT fdmt-20230331_htm.xml XML 2117248
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39782 | Film No.: 23908096
SIC: 2836 Biological Products, (No Diagnostic Substances)